135 related articles for article (PubMed ID: 16432549)
1. The influence of a 3-month weight reduction therapy with Orlistat on serum vitamin B12 and folic acid concentration in obese women.
Holecki M; Zahorska-Markiewicz B; Nieszporek T; Mizia-Stec K; Olszanecka-Glinianowicz M; Zak-Gołab A; Kocełak P; Wiecek A
Int J Obes (Lond); 2006 Jun; 30(6):1017-8. PubMed ID: 16432549
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
3. Orlistat increases serum paraoxonase activity in obese patients.
Audikovszky M; Pados G; Seres I; Harangi M; Fülöp P; Katona E; Illyés L; Winkler G; Katona EM; Paragh G
Nutr Metab Cardiovasc Dis; 2007 May; 17(4):268-73. PubMed ID: 17134960
[TBL] [Abstract][Full Text] [Related]
4. Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.
Svendsen M; Rissanen A; Richelsen B; Rössner S; Hansson F; Tonstad S
Obesity (Silver Spring); 2008 Feb; 16(2):327-33. PubMed ID: 18239640
[TBL] [Abstract][Full Text] [Related]
5. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels.
Yesilbursa D; Serdar Z; Serdar A; Sarac M; Coskun S; Jale C
Int J Obes (Lond); 2005 Jan; 29(1):142-5. PubMed ID: 15467775
[TBL] [Abstract][Full Text] [Related]
7. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women.
Holecki M; Zahorska-Markiewicz B; Janowska J; Nieszporek T; Wojaczyńska-Stanek K; Zak-Gołab A; Wiecek A
Obesity (Silver Spring); 2007 Aug; 15(8):1925-9. PubMed ID: 17712108
[TBL] [Abstract][Full Text] [Related]
8. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
[TBL] [Abstract][Full Text] [Related]
9. Serum homocysteine, B12 and folic acid concentration in Thai overweight and obese subjects.
Tungtrongchitr R; Pongpaew P; Tongboonchoo C; Vudhivai N; Changbumrung S; Tungtrongchitr A; Phonrat B; Viroonudomphol D; Pooudong S; Schelp FP
Int J Vitam Nutr Res; 2003 Feb; 73(1):8-14. PubMed ID: 12690905
[TBL] [Abstract][Full Text] [Related]
10. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women.
Sheu WH; Chin HM; Lee WJ; Wan CJ; Su HY; Lang HF
Life Sci; 2005 Mar; 76(18):2137-45. PubMed ID: 15826880
[TBL] [Abstract][Full Text] [Related]
12. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
Chou KM; Huang BY; Fanchiang JK; Chen CH
Chang Gung Med J; 2007; 30(6):538-46. PubMed ID: 18350737
[TBL] [Abstract][Full Text] [Related]
14. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects.
Ahnen DJ; Guerciolini R; Hauptman J; Blotner S; Woods CJ; Wargovich MJ
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1291-9. PubMed ID: 17920338
[TBL] [Abstract][Full Text] [Related]
15. Folate, vitamin B12 and homocysteine status in women of childbearing age: baseline data of folic acid wheat flour fortification in Iran.
Abdollahi Z; Elmadfa I; Djazayeri A; Sadeghian S; Freisling H; Mazandarani FS; Mohamed K
Ann Nutr Metab; 2008; 53(2):143-50. PubMed ID: 18997463
[TBL] [Abstract][Full Text] [Related]
16. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients.
Harrison SA; Fincke C; Helinski D; Torgerson S; Hayashi P
Aliment Pharmacol Ther; 2004 Sep; 20(6):623-8. PubMed ID: 15352910
[TBL] [Abstract][Full Text] [Related]
18. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
Svendsen M; Helgeland M; Tonstad S
J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
[TBL] [Abstract][Full Text] [Related]
19. Weight change and blood coagulability and fibrinolysis in healthy obese women.
Rissanen P; Vahtera E; Krusius T; Uusitupa M; Rissanen A
Int J Obes Relat Metab Disord; 2001 Feb; 25(2):212-8. PubMed ID: 11410822
[TBL] [Abstract][Full Text] [Related]
20. The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women.
Diamanti-Kandarakis E; Piperi C; Alexandraki KI; Papailiou J; Ekonomou F; Koulouri E; Kandarakis H; Creatsas G
Minerva Endocrinol; 2009 Jun; 34(2):97-104. PubMed ID: 19471234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
